Operating Lease, Right-of-Use Asset of Omega Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Omega Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2024.
  • Omega Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $109,245,000, a 0.77% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Omega Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $109,245,000 -$849,000 -0.77% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $107,191,000 +$9,118,000 +9.3% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $107,362,000 +$104,630,000 +3830% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $108,736,000 +$105,068,000 +2864% 31 Dec 2023 10-Q 14 Nov 2024 2024 Q3
Q3 2023 $110,094,000 +$105,495,000 +2294% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $98,073,000 +$92,548,000 +1675% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $2,732,000 -$3,711,000 -58% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $3,668,000 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $4,599,000 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $5,525,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $6,443,000 31 Mar 2022 10-Q 04 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.